Skip to content
GCC AI Research

Search

Results for "pandemic"

Portable COVID-19 test revolutionizes detection

KAUST ·

A KAUST-led team developed NIRVANA, a portable, briefcase-sized device for rapid detection and sequencing of SARS-CoV-2, influenza, and other viruses. The test utilizes isothermal recombinase amplification (RPA) and was validated on clinical samples and wastewater. NIRVANA can differentiate SARS-CoV-2 strains and doesn't require expensive infrastructure. Why it matters: This innovation enables rapid, decentralized virus detection and surveillance, crucial for pandemic response and monitoring new variants across the region.

Forecasting hospitalizations with AI

MBZUAI ·

MBZUAI Professor Agathe Guilloux developed the SigLasso model to forecast hospitalizations using real-time data from Google and Météo France during the COVID-19 pandemic. The model integrates mobility data and weather patterns to predict hospitalization rates 10-14 days in advance. SigLasso outperformed industry standards like GRU and Neural CDE in reducing reconstruction error. Why it matters: This research demonstrates the potential of AI to improve healthcare resource allocation and crisis management by accurately predicting patient flow using readily available data.

KAUST and NHK sign agreement to document the Red Sea using high-definition, 8K technology

KAUST ·

KAUST and Japan's NHK have signed an agreement for NHK to film the Red Sea in 8K high-definition as part of the "Deep Ocean" documentary series. The filming will be coordinated with researchers from KAUST's Red Sea Research Center, covering a range of subjects from coral reefs to deep-sea brine pools. The collaboration, initiated in 2019, was delayed due to the COVID-19 pandemic. Why it matters: This partnership will showcase the Red Sea's unique biodiversity and KAUST's marine research capabilities to a global audience, highlighting Saudi Arabia's focus on environmental research and its Red Sea giga-projects.

Novel ventilator delivers more than oxygen

KAUST ·

KAUST researchers developed VENTIBAG, a mobile AI-powered ventilator, in response to the COVID-19 pandemic. The device extracts and delivers pure oxygen, adjusting support based on real-time monitoring of the patient's condition via cloud connectivity. Funded by a KAUST Innovation Challenge grant, the portable ventilator is now advancing to the testing stage for medical applications. Why it matters: This innovation addresses critical needs for remote patient care and reducing hospital overcrowding, particularly relevant in resource-constrained environments.

Innovation in the time of COVID-19: How we turned unprecedented challenge into opportunity

KAUST ·

KAUST responded to the COVID-19 pandemic by focusing on scientific research and innovation, including pivoting existing startups to address new challenges. Wayakit, a KAUST startup, adapted its disinfectant product for safer air travel and partnered with Swissport International for use in Saudi airports. KAUST also joined the University-Industry Demonstration Partnership (UIDP) and the Stanford-led Open IP Access Framework to accelerate technology transfer. Why it matters: This highlights the role of research universities in rapidly translating scientific findings into practical solutions during crises, and KAUST's efforts to bridge academia and industry.

KAUST and Lean Business Services sign collaboration to advance digital healthcare in Saudi Arabia

KAUST ·

KAUST and Lean Business Services (the digital arm of the Saudi health sector) have signed a Memorandum of Understanding to advance AI and data science for a "smart health" ecosystem in Saudi Arabia. During the COVID-19 pandemic, they collaborated to provide the Saudi Ministry of Health with AI-driven trends and analysis. KAUST's Shaheen II supercomputer was utilized to process healthcare data. Why it matters: This partnership aims to develop AI and advanced analytics solutions to enhance healthcare access, quality, and cost-efficiency in line with Saudi Vision 2030.

President Chan's address on community testing

KAUST ·

KAUST President announced a mandatory COVID-19 screening program for employees and students from November 1-5. The program aims to provide snapshots of COVID-19 prevalence in the community to inform healthcare demands and future plans. The university targets 5,000 individual swabs in partnership with the Ministry of Health, and participation is crucial for the program's success. Why it matters: This proactive measure enables KAUST to maintain a safe environment and continue reopening the campus, setting an example for managing the pandemic sustainably in the region.